The global therapeutic diet for pet market reflects a remarkable trajectory from 2024 to 2034, indicating a robust growth rate. After a thorough survey, the market growth equates to a sluggish CAGR of 4.0% during the forecast period. With an initial forecast of US$ 502.4 million in 2024, the market is witnessing a significant increase to US$ 744.5 million by 2034.
| Attributes | Key Insights |
|---|---|
| Therapeutic Diet for Pet Market Size (2024E) | US$ 502.4 million |
| Therapeutic Diet for Pet Industry Value (2034F) | US$ 744.5 million |
| Value-based CAGR (2024 to 2034) | 4.0% |
Rising pet ownership rates and consumer spending on veterinary meals tailored to individual pet health needs are fueling market growth. The United States and Europe have leading dog populations due to their developing pet ecosystems and accessibility to adoption & purchase from animal shelters.
Pet owners worldwide are looking for more personalized nutrition solutions for their pets, which is surging the demand for therapeutic diets that cater to individual pet health needs, preferences, and dietary restrictions. Also, ongoing research and studies on pet nutrition & related science, ingredient technology developments, and product formulations are fueling growth and innovation in the market.
Consulting with a veterinarian is essential for determining the most suitable therapeutic diet for each pet's unique health requirements. By providing tailored nutrition and adhering to veterinarian recommendations, pet owners can significantly enhance their furry companions' quality of life and longevity. Furthermore, the market is growing due to the rise in pet digestive issues and increasing concern for dental & oral health issues in dogs.
Don't pay for what you don't need
Customize your report by selecting specific countries or regions and save 30%!
The demand for therapeutic diets for pets is divined to develop rapidly. The historical CAGR of 2.6% was recorded for the market, and a 4.0% CAGR is estimated through 2034. The veterinary field has advanced, and evaluation of pet dietary requirements, particularly those with specific medical issues, has increased.
Veterinarians, as key influencers, are increasingly suggesting therapeutic diets as part of treatment regimens for various illnesses, underscoring the main role of pet food producers and manufacturers in meeting these evolving needs. Several pet owners recognized the importance of diet in maintaining their animals' health, with growing demand for therapeutic diets to address common health disorders like obesity, diabetes, and food allergies.
From 2019 to 2023, pet food producers and manufacturers invested in research & development to create unique therapeutic diets catering to specific pet health needs. This includes using progressive ingredients, innovative formulation methods, and empirical research to prevent the growth of diseases like dental or joint problems.
The demand for personalized pet food is increasing, propelled by pet owners' specific dietary needs and health conditions, leading to the development of specialized formulations. E-commerce platforms are projected to gain traction in the market amid increasing online pet food sales due to easy and direct home delivery in less time.
Pet owners are demonstrating a heightened sense of responsibility toward their pets' health and well-being, leading to a growing demand for specialized therapeutic diets to address specific health conditions and nutritional needs. This trend is a testament to the evolving pet care landscape, where owners are increasingly motivated to provide the best possible care for their beloved companions.
The rising number of pets is increasingly seen as a sign of wealth and sophistication in society, particularly in the United States and Europe. The trend toward grain-free and gluten-free pet food continues to grow, propelled by concerns over pet allergies and digestive issues.
Principal Consultant
According to statistical data, industries in the United Kingdom and the United States are envisioned to develop relatively well in the next decade. Meanwhile, the industry in Germany and China is experiencing a substantial shift due to various factors. The industry in India is also anticipated to mature extensively in the upcoming decade.
| Countries | Market Value (2034) |
|---|---|
| United States | US$ 305.6 million |
| United Kingdom | US$ 23.5 million |
| Germany | US$ 26.1 million |
| China | US$ 19.7 million |
| India | US$ 10.8 million |
The table below shows the estimated growth rates of the leading five countries. The United States, the United Kingdom, and Germany are set to record CAGRs of 5.1%, 4.3%, and 4.0%, respectively, through 2034.
| Countries | CAGR (2024 to 2034) |
|---|---|
| United States | 5.1% |
| United Kingdom | 4.3% |
| Germany | 4.0% |
| China | 3.8% |
| India | 3.5% |
Pet owners are increasingly focused on preventive health care for their pets, fueling the demand for therapeutic diets that support immune function, digestive health, and disease prevention. Millennials in the United States are very concerned about pet health and always look for better food products and medicated treatment for faster results.
Consumers in the United States tend to spend a lot on their pet's medical treatment to fight allergies and age-related issues. The rise in pet obesity in the United States has led to a growing need for specialized therapeutic diets designed to manage weight and support healthy weight loss in pets. Nowadays, allergies are common in pets, and demand for hypoallergenic therapeutic diets that address food sensitivities and skin issues is on the rise.
With an aging pet population in the United States, there is a growing need for therapeutic diets that support joint health, cognitive function, and wellness in senior pets. For instance, Farmina Vet Life Diabetic is a complete diabetic food for adult dogs, suggested for the regulation of glucose supply (diabetes mellitus) and the reduction of excessive body weight.
Growing health issues among pets, such as excessive gas, skin irritation, loose stools, and various ear & skin infections, propel the demand for a therapeutic diet for pets. A therapeutic diet for pets promotes a healthy, shiny coat with soft skin, enhances digestive & immune systems, and is beneficial for pet owners.
Manufacturers in Germany are investing in research & development to produce quality products and increase the nutritional value of pet food. Pet owners are increasingly spending on healthy pet foods due to surging awareness of intolerances and allergies. The demand for hypoallergenic pet food combinations has risen by 75%, with suppliers incorporating omega-3 fatty acids and diabetic products into their offerings.
Pet ownership in China is increasing, with several owners viewing their pets as part of the family. This has led to rising spending on veterinary care, including specialist diets.
Pet owners are becoming more aware of diet's role in maintaining their animals' health and treating various ailments. Veterinarians are increasingly recommending specialized diets as part of therapy regimens for certain diseases, fueling demand for therapeutic diets for pets in China.
Pet food manufacturers in India are constantly innovating to meet the nutritional needs of pets with health concerns. They use innovative ingredients and formulas supported by empirical data.
With the growth of e-commerce, pet owners have access to a wide range of therapeutic meals, offering greater convenience and a wider selection than traditional stores in India. Humanization of pets has led to a greater willingness to invest in specialized, high-quality items like therapeutic diets, ensuring pet’s health and well-being.
The segmented therapeutic diet for pet market analysis is included in the following subsection. Based on comprehensive studies, the cat segment is prevailing in the age group category. Similarly, the kidney disease segment is governing the health condition category.
| Segment | CAGR (2024 to 2034) |
|---|---|
| Cat (Age Group) | 4.6% |
| Kidney Disease (Health Condition) | 2.8% |
E-commerce platforms are surging globally, making the process of purchasing products easier and more informative for pet owners. Customers are becoming more concerned about product specifications. Online buying options offer various options, surpassing consumer demand.
Direct doorstep delivery, minimal charges, and emerging online distribution channels are the key factors fueling demand for therapeutic diets for pets through online distribution channels. Online platforms also provide detailed product solutions & comparisons, nutritional information, and customer reviews. These help pet owners compare brands, products, and ingredients quantity.
Pet food manufacturers are developing prescription diets for animals with kidney disease, limiting certain nutrients like protein and phosphorus to reduce kidney strain. This innovation is based on ongoing research and veterinarian advice, enhancing their products' nutritional balance, palatability, and efficacy.
Chronic kidney disease is a prevalent condition in senior dogs and cats. As pets live longer, the need for therapeutic diets to promote kidney health is surging. Therapeutic diets are essential for treating renal disease in pets, meeting other dietary needs, lowering phosphorus levels, and supporting renal function.
Get the data you need at a Fraction of the cost
Personalize your report by choosing insights you need
and save 40%!
Hill's, Purina, Royal Canin, Blue Buffalo, Orijen, Nature's Variety, Wellness, Ziwi, Solid Gold, Taste of the Wild, and Virbac are the key manufacturers of therapeutic diets for pets. Increasing demand for therapeutic diets for the pet market among consumers has convinced manufacturers to invest heavily in the research & development of innovative and new variations of products.
Recent Developments:
The market is set to be valued at US$ 502.4 million in 2024.
The industry is marked to be valued at US$ 744.5 million by 2034.
North America is set to hold a market share of 46.8% by 2034.
Hill’s, Purina, Royal Canin, and Blue Buffalo are the prominent players in the market.
The industry is set to register a CAGR of 4.0% from 2024 to 2034.
In India, demand is anticipated to develop at a CAGR of 3.5% through 2034.
1. Executive Summary
1.1. Global Market Outlook
1.2. Demand Side Trends
1.3. Supply Side Trends
1.4. Technology Roadmap
1.5. Analysis and Recommendations
2. Market Overview
2.1. Market Coverage / Taxonomy
2.2. Market Definition
3. Market Background
3.1. Drivers
3.1.1. Supply Side Drivers
3.1.2. Demand Side drivers
3.1.3. Economic Side Drivers
3.2. Restraints
3.3. Opportunity
3.4. Market trends by Region
3.5. Forecast Factors - Relevance & Impact
3.6. Regulations and Policies
4. Global Market- Pricing Analysis
4.1. Price Point Assessment by Region
4.1.1. Manufacturer Level Pricing
4.1.2. Distributor Level Pricing
4.1.3. Retail Level Pricing
4.2. Price Point Assessment by Pet Type
4.3. Price Forecast till 2034
5. Value Chain Analysis
5.1. Operating margins at each node of supply chain
5.2. List of Active Market Participants
6. Global Market Size in Value (US$ million) and Volume (MT) Analysis 2019 to 2023 and Forecast, 2024 to 2034
6.1. Historical Market Size in Value (US$ million) and Volume (MT) Analysis, 2019 to 2023
6.2. Current and Future Market Size in Value (US$ million) and Volume (MT) Analysis, 2024 to 2034
6.2.1. Y-o-Y Growth Trend Analysis
6.2.2. Absolute $ Opportunity Analysis
7. Global Market Analysis 2019 to 2023 and Forecast 2024 to 2034, by Age Group
7.1. Introduction / Key Findings
7.2. Historical Market Size in Value (US$ million) and Volume (MT) Analysis by Age Group , 2019 to 2023
7.3. Current and Future Market Size in Value (US$ million) and Volume (MT) Analysis and Forecast by Age Group , 2024 to 2034
7.3.1. Cat
7.3.1.1. Kitten
7.3.1.2. Adult
7.3.1.3. Senior
7.3.2. Dog
7.3.2.1. Puppy
7.3.2.2. Adult
7.3.2.3. Senior
7.4. Market Attractiveness Analysis by Age Group
8. Global Market Analysis 2019 to 2023 and Forecast 2024 to 2034, by Distribution Channel
8.1. Introduction / Key Findings
8.2. Historical Market Size in Value (US$ million) and Volume (MT) Analysis by Distribution Channel, 2019 to 2023
8.3. Current and Future Market Size in Value (US$ million) and Volume (MT) Analysis and Forecast by Distribution Channel, 2024 to 2034
8.3.1. Offline
8.3.2. Online
8.4. Market Attractiveness Analysis by Distribution Channel
9. Global Market Analysis 2019 to 2023 and Forecast 2024 to 2034, by Health Condition
9.1. Introduction / Key Findings
9.2. Historical Market Size in Value (US$ million) and Volume (MT) Analysis by Health Condition, 2019 to 2023
9.3. Current and Future Market Size in Value (US$ million) and Volume (MT) Analysis and Forecast by Health Condition, 2024 to 2034
9.3.1. Kidney Disease
9.3.2. Weight Management Problems
9.3.3. Arthritis and Other Orthopedic Conditions
9.3.4. Skin and/or Coat Health Problems
9.3.5. Oncology Support
9.3.6. Food Allergies
9.3.7. Diabetes and Other Endocrine Disorders
9.3.8. Gastrointestinal Issues
9.3.9. Liver Disease
9.3.10. Periodontal Disease/ Oral Health
9.3.11. Cognitive Health
9.4. Market Attractiveness Analysis by Health Condition
10. Global Market Analysis 2019 to 2023 and Forecast 2024 to 2034, by Region
10.1. Introduction
10.2. Historical Market Size in Value (US$ million) and Volume (MT) Analysis by Region, 2019 to 2023
10.3. Current Market Size in Value (US$ million) and Volume (MT) Analysis and Forecast by Region, 2024 to 2034
10.3.1. North America
10.3.2. Latin America
10.3.3. Europe
10.3.4. East Asia
10.3.5. South Asia
10.3.6. Oceania
10.3.7. Middle East & Africa
10.4. Market Attractiveness Analysis by Region
11. North America Market Analysis 2019 to 2023 and Forecast 2024 to 2034
11.1. Introduction
11.2. Historical Market Size (US$ million) and Volume(MT) Trend Analysis by Market Taxonomy, 2019 to 2023
11.3. Market Size (US$ million) and Volume(MT) Forecast by Market Taxonomy, 2024 to 2034
11.3.1. by Country
11.3.1.1. United States
11.3.1.2. Canada
11.3.2. by Age Group
11.3.3. by Distribution Channel
11.3.4. by Health Condition
11.4. Market Attractiveness Analysis
11.4.1. by Country
11.4.2. by Age Group
11.4.3. by Distribution Channel
11.4.4. by Health Condition
11.5. Key takeaways
12. Latin America Market Analysis 2019 to 2023 and Forecast 2024 to 2034
12.1. Introduction
12.2. Historical Market Size (US$ million) and Volume(MT) Trend Analysis by Market Taxonomy, 2019 to 2023
12.3. Market Size (US$ million) and Volume (MT) Forecast by Market Taxonomy, 2024 to 2034
12.3.1. by Country
12.3.1.1. Brazil
12.3.1.2. Mexico
12.3.1.3. Argentina
12.3.1.4. Rest of Latin America
12.3.2. by Age Group
12.3.3. by Distribution Channel
12.3.4. by Health Condition
12.4. Market Attractiveness Analysis
12.4.1. by Country
12.4.2. by Age Group
12.4.3. by Distribution Channel
12.4.4. by Health Condition
12.5. Key takeaways
13. Europe Market Analysis 2019 to 2023 and Forecast 2024 to 2034
13.1. Introduction
13.2. Historical Market Size (US$ million) and Volume(MT) Trend Analysis by Market Taxonomy, 2019 to 2023
13.3. Market Size (US$ million) and Volume(MT) Forecast by Market Taxonomy, 2024 to 2034
13.3.1. by Country
13.3.1.1. Germany
13.3.1.2. United Kingdom
13.3.1.3. France
13.3.1.4. Italy
13.3.1.5. Spain
13.3.1.6. BENELUX
13.3.1.7. Nordic
13.3.1.8. Russia
13.3.1.9. Poland
13.3.1.10. Rest of Europe
13.3.2. by Age Group
13.3.3. by Distribution Channel
13.3.4. by Health Condition
13.4. Market Attractiveness Analysis
13.4.1. by Country
13.4.2. by Age Group
13.4.3. by Distribution Channel
13.4.4. by Health Condition
13.5. Key takeaways
14. East Asia Market Analysis 2019 to 2023 and Forecast 2024 to 2034
14.1. Introduction
14.2. Historical Market Size (US$ million) and Volume(MT) Trend Analysis by Market Taxonomy, 2019 to 2023
14.3. Market Size (US$ million) and Volume(MT) Forecast by Market Taxonomy, 2024 to 2034
14.3.1. by Country
14.3.1.1. China
14.3.1.2. Japan
14.3.1.3. South Korea
14.3.2. by Age Group
14.3.3. by Distribution Channel
14.3.4. by Health Condition
14.4. Market Attractiveness Analysis
14.4.1. by Country
14.4.2. by Age Group
14.4.3. by Distribution Channel
14.4.4. by Health Condition
14.5. Key takeaways
15. South Asia Market Analysis 2019 to 2023 and Forecast 2024 to 2034
15.1. Introduction
15.2. Historical Market Size (US$ million) and Volume(MT) Trend Analysis by Market Taxonomy, 2019 to 2023
15.3. Market Size (US$ million) and Volume(MT) Forecast by Market Taxonomy, 2024 to 2034
15.3.1. by Country
15.3.1.1. India
15.3.1.2. Thailand
15.3.1.3. Malaysia
15.3.1.4. Indonesia
15.3.1.5. Vietnam
15.3.1.6. Philippines
15.3.1.7. Singapore
15.3.1.8. Rest of South Asia
15.3.2. by Age Group
15.3.3. by Distribution Channel
15.3.4. by Health Condition
15.4. Market Attractiveness Analysis
15.4.1. by Country
15.4.2. by Age Group
15.4.3. by Distribution Channel
15.4.4. by Health Condition
15.5. Key takeaways
16. Oceania Market Analysis 2019 to 2023 and Forecast 2024 to 2034
16.1. Introduction
16.2. Historical Market Size (US$ million) and Volume(MT) Trend Analysis by Market Taxonomy, 2019 to 2023
16.3. Market Size (US$ million) and Volume(MT) Forecast by Market Taxonomy, 2024 to 2034
16.3.1. by Country
16.3.1.1. Australia
16.3.1.2. New Zealand
16.3.2. by Age Group
16.3.3. by Distribution Channel
16.3.4. by Health Condition
16.4. Market Attractiveness Analysis
16.4.1. by Country
16.4.2. by Age Group
16.4.3. by Distribution Channel
16.4.4. by Health Condition
16.5. Key takeaways
17. Middle East and Africa Market Analysis 2019 to 2023 and Forecast 2024 to 2034
17.1. Introduction
17.2. Historical Market Size (US$ million) and Volume(MT) Trend Analysis by Market Taxonomy, 2019 to 2023
17.3. Market Size (US$ million) and Volume(MT) Forecast by Market Taxonomy, 2024 to 2034
17.3.1. by Country
17.3.1.1. GCC Countries
17.3.1.2. Turkiye
17.3.1.3. Egypt
17.3.1.4. South Africa
17.3.1.5. Rest of Middle East and Africa
17.3.2. by Age Group
17.3.3. by Distribution Channel
17.3.4. by Health Condition
17.4. Market Attractiveness Analysis
17.4.1. by Country
17.4.2. by Age Group
17.4.3. by Distribution Channel
17.4.4. by Health Condition
17.5. Key takeaways
18. Country-level Market Analysis, 2024
18.1. United States Market Analysis
18.1.1. by Age Group
18.1.2. by Distribution Channel
18.1.3. by Health Condition
18.2. Canada Market Analysis
18.2.1. by Age Group
18.2.2. by Distribution Channel
18.2.3. by Health Condition
18.3. Brazil Market Analysis
18.3.1. by Age Group
18.3.2. by Distribution Channel
18.3.3. by Health Condition
18.4. Mexico Market Analysis
18.4.1. by Age Group
18.4.2. by Distribution Channel
18.4.3. by Health Condition
18.5. Argentina Market Analysis
18.5.1. by Age Group
18.5.2. by Distribution Channel
18.5.3. by Health Condition
18.6. Germany Market Analysis
18.6.1. by Age Group
18.6.2. by Distribution Channel
18.6.3. by Health Condition
18.7. United Kingdom Market Analysis
18.7.1. by Age Group
18.7.2. by Distribution Channel
18.7.3. by Health Condition
18.8. France Market Analysis
18.8.1. by Age Group
18.8.2. by Distribution Channel
18.8.3. by Health Condition
18.9. Italy Market Analysis
18.9.1. by Age Group
18.9.2. by Distribution Channel
18.9.3. by Health Condition
18.10. Spain Market Analysis
18.10.1. by Age Group
18.10.2. by Distribution Channel
18.10.3. by Health Condition
18.11. BENELUX Market Analysis
18.11.1. by Age Group
18.11.2. by Distribution Channel
18.11.3. by Health Condition
18.12. Nordic Market Analysis
18.12.1. by Age Group
18.12.2. by Distribution Channel
18.12.3. by Health Condition
18.13. Russia Region Market Analysis
18.13.1. by Age Group
18.13.2. by Distribution Channel
18.13.3. by Health Condition
18.14. Poland Market Analysis
18.14.1. by Age Group
18.14.2. by Distribution Channel
18.14.3. by Health Condition
18.15. China Market Analysis
18.15.1. by Age Group
18.15.2. by Distribution Channel
18.15.3. by Health Condition
18.16. Japan Market Analysis
18.16.1. by Age Group
18.16.2. by Distribution Channel
18.16.3. by Health Condition
18.17. South Korea Market Analysis
18.17.1. by Age Group
18.17.2. by Distribution Channel
18.17.3. by Health Condition
18.18. India Market Analysis
18.18.1. by Age Group
18.18.2. by Distribution Channel
18.18.3. by Health Condition
18.19. Thailand Market Analysis
18.19.1. by Age Group
18.19.2. by Distribution Channel
18.19.3. by Health Condition
18.20. Malaysia Market Analysis
18.20.1. by Age Group
18.20.2. by Distribution Channel
18.20.3. by Health Condition
18.21. Indonesia Market Analysis
18.21.1. by Age Group
18.21.2. by Distribution Channel
18.21.3. by Health Condition
18.22. Vietnam Market Analysis
18.22.1. by Age Group
18.22.2. by Distribution Channel
18.22.3. by Health Condition
18.23. Philippines Market Analysis
18.23.1. by Age Group
18.23.2. by Distribution Channel
18.23.3. by Health Condition
18.24. Singapore Market Analysis
18.24.1. by Age Group
18.24.2. by Distribution Channel
18.24.3. by Health Condition
18.25. Australia Market Analysis
18.25.1. by Age Group
18.25.2. by Distribution Channel
18.25.3. by Health Condition
18.26. New Zealand Market Analysis
18.26.1. by Age Group
18.26.2. by Distribution Channel
18.26.3. by Health Condition
18.27. GCC Countries Market Analysis
18.27.1. by Age Group
18.27.2. by Distribution Channel
18.27.3. by Health Condition
18.28. Turkiye Market Analysis
18.28.1. by Age Group
18.28.2. by Distribution Channel
18.28.3. by Health Condition
18.29. Egypt Market Analysis
18.29.1. by Age Group
18.29.2. by Distribution Channel
18.29.3. by Health Condition
18.30. South Africa Market Analysis
18.30.1. by Age Group
18.30.2. by Distribution Channel
18.30.3. by Health Condition
19. Market Structure Analysis
19.1. Global Market Competition - a Dashboard View
19.2. Industry Structure Analysis
19.2.1. % tier 1 market players
19.2.2. % tier 2 market players
19.2.3. % tier 3 market players
19.3. Global Market Company Share Analysis
19.3.1. For Tier 1 Market Players, 2023
19.3.2. Company Market Share Analysis of Top 5 Players, by Region
19.4. Key Participants Market Presence (Intensity Mapping) by Region
20. Competition Analysis
20.1. Competition Dashboard
20.2. Competition Benchmarking
20.3. Competition Deep Dive
20.3.1. Hill’s
20.3.1.1. Age Group Portfolio
20.3.1.2. Distribution Channel
20.3.1.3. Revenue by Market Segments (Age Group/Channel/Region)
20.3.1.4. Sales Footprint
20.3.1.5. Strategy Overview
20.3.1.5.1. Marketing Strategy
20.3.1.5.2. Age Group Strategy
20.3.1.5.3. Channel Strategy
20.3.1.6. SWOT Analysis
20.3.1.7. Purina
20.3.1.8. Royal Canin
20.3.1.9. Blue Buffalo
20.3.1.10. Orijen
20.3.1.11. Nature’s Variety
20.3.1.12. Wellness
20.3.1.13. Ziwi
20.3.1.14. Solid Gold
20.3.1.15. Taste of the Wild
20.3.1.16. Virbac
21. Assumption & Acronyms
22. Research Methodology
Explore Food and Beverage Insights
View Reports
Therapeutic Diet for Pet Market
